Dr. Wrzesinski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
43 New Scotland Ave
# 7
Albany, NY 12208Phone+1 518-262-6696Fax+1 518-262-2624
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2002 - 2005
SUNY Upstate Medical UniversityClass of 2002
Certifications & Licensure
NY State Medical License 2011 - 2026
CT State Medical License 2006 - 2011- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
- A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
- Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040) Start of enrollment: 2014 Nov 17
- Join now to see all
Publications & Presentations
PubMed
- 258 citationsInhibition of Bruton tyrosine kinase in patients with severe COVID-19.Mark Roschewski, Michail S. Lionakis, Jeff P. Sharman, Joseph Roswarski, Andre Goy
Science Immunology. 2020-06-05 - 715 citationsThe polarization of immune cells in the tumour environment by TGFβRichard A. Flavell, Shomyseh Sanjabi, Stephen H. Wrzesinski, Paula Licona-Limón
Nature Reviews. Immunology. 2010-07-09 - 336 citationsTransforming Growth Factor-β and the Immune Response: Implications for Anticancer TherapyStephen H. Wrzesinski, Yisong Y. Wan, Richard A. Flavell
Clinical Cancer Research. 2007-09-15
Press Mentions
Preliminary Research Involving Members of the US Oncology Network Finds Cancer Drug May Benefit Advanced COVID-19 PatientsJune 5th, 2020- Local Doctors and Patients Part of a Promising Drug Study on a New Covid-19 TreatmentJune 5th, 2020
- Study Looks at Cancer Drug to Treat COVID-19June 5th, 2020
Professional Memberships
- Member
- Member
- Society for Immunotherapy of Cancer (SITC)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
